SPOTLIGHT -
Recent studies and reviews report great progress in bringing TD under control.
The 2024 APA Annual Meeting: Monday, May 6
Treating ‘Morally Objectionable’ Patients
Cognitive Impairment and Upcoming Agents for Long-Acting Schizophrenia Treatment
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Tardive Dyskinesia in US Antipsychotic Users
An Update on Muscarinic Agonism as a Treatment for Schizophrenia